With advances in molecular neuroimaging, PET tracers targeting dopamine transporters (DAT) could reflect the functional integrity of dopaminergic neurons in the striatum [3], which has emerged as an important tool in the evaluation of PD [4]. This evidence concerns the gene SLC6A3 and Parkinson disease.